WallStreetZenWallStreetZen

NASDAQ: TRDA
Entrada Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Entrada Therapeutics revenue was $172.22M for the trailing 12 months ending Mar 31, 2025, with 15.7% growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $20.6M, down 45% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TRDA annual revenue was $210.8M, with 63.4% growth year-over-year.

TRDA past revenue growth

How has TRDA's revenue growth performed historically?

Company
5.74%
Industry
1,361.15%
Market
34.96%
TRDA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TRDA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TRDA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TRDA revenue history

Current Revenue
$172.2M
Current Earnings
$24.8M
Current Profit Margin
14.4%

Be the first to know when TRDA announces revenue.

TRDA Revenue History By Year

TRDA Yearly RevenueTRDA RevenueTRDA ChangeTRDA Revenue Growth
2024-12-31$210.78M$81.77M+63.38%
2023-12-31$129.01MN/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Entrada Therapeutics Revenue FAQ

What was TRDA's revenue last quarter?

On Invalid Date, Entrada Therapeutics (NASDAQ: TRDA) reported Q1 2025 revenue of $20.56 million up 65.23% year over year. In the same quarter last year, Entrada Therapeutics's revenue was $59.12 million.

What was Entrada Therapeutics's revenue in 2024?

Entrada Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $210.78 million, a 63.38% increase year over year.

How much does Entrada Therapeutics make in a day?

Based on Entrada Therapeutics annual revenue for the past five years, TRDA makes an average of $186,189.04 per day.

What was Entrada Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Entrada Therapeutics's revenue has grown 5.74% year over year. This is 1,355.41 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Entrada Therapeutics's revenue in the past year totaled $172.22 million.

How much does Entrada Therapeutics make in a year?

Entrada Therapeutics's revenue by year for the past five years is:
  • Entrada Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $210.78 million, a 63.38% increase year over year.
  • Entrada Therapeutics's annual revenue for Dec 31, 2023 was $129.01 million, a Infinity% increase from 2022.
  • Entrada Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Entrada Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Entrada Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.